Rakesh Jhunjhunwala’s Multibagger Pharma Stock Reports Clinical Breakthrough in Combating Serious Illness Rakesh Jhunjhunwala’s Multibagger Pharma Stock Reports Clinical Breakthrough in Combating Serious Illness In the last one year, its share price has surged by 201.81 per cent Karan Dsij / Monday, January 13, 2025 0 523 Article rating: 4.0 The shareholding pattern reveals that the estate of ace investor Late Rakesh Jhunjhunwala holds a 1.75 per cent stake in the company, amounting to over 28 lakh shares Read more
Double Dhamaka! 1:1 Bonus Share & 5:1 Stock Split: Multibagger pharma stock jumps 14.6 per cent; Promoters bought 13,02,000 shares! Double Dhamaka! 1:1 Bonus Share & 5:1 Stock Split: Multibagger pharma stock jumps 14.6 per cent; Promoters bought 13,02,000 shares! From Rs 38.05 to Rs 198.80 per share, the stock gave multibagger returns of over 400 per cent in 3 years. Kiran Shroff / Thursday, August 29, 2024 2 1020 Article rating: 4.3 In July 2024, the promoters of the company bought 13,02,000 shares and increased their stake to 31.61 per cent compared to 26.32 per cent in June 2024. Read more
Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside! Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside! From Rs 35.03 per share (52-week low) to Rs 62.49 per share, the stock is up by 78.4 per cent and gave multibagger returns of 115 per cent in 2 years. Kiran Shroff / Tuesday, August 20, 2024 0 2169 Article rating: 3.7 From Rs 35.03 per share (52-week low) to Rs 62.49 per share, the stock is up by 78.4 per cent and gave multibagger returns of 115 per cent in 2 years. Read more
Multibagger penny stock under Rs 60 with 200 per cent returns: Heavy buying witnessed in this pharma stock; PAT jumps over 240 per cent! Multibagger penny stock under Rs 60 with 200 per cent returns: Heavy buying witnessed in this pharma stock; PAT jumps over 240 per cent! Shares of the company gained more than 10 per cent in the last six months. Praveenkumar Yadav / Friday, June 28, 2024 0 5809 Article rating: 4.0 Shares of the company gained more than 10 per cent in the last six months. Read more
Record high FIIs stake in this multibagger pharma stock: Exploring the key tailwinds! Record high FIIs stake in this multibagger pharma stock: Exploring the key tailwinds! The company saw strong volume growth across key markets, particularly the US, indicating rising demand for their products. Aniket Gogate / Wednesday, February 21, 2024 0 7985 Article rating: 4.0 Institutional investor interest in the stock has risen significantly, with Foreign Institutional Investor (FII) holdings increasing to 15.55 per cent in the quarter ending December 2023 from 4.23 per cent in December 2022. Read more